Astec LifeSciences per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−₹35.71−₹37.79−₹68.71−₹23.93₹13.04
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−₹35.71−₹37.79−₹68.71−₹23.93₹13.04
₹175.30₹175.30₹119.70₹188.32₹213.90
₹196.99₹201.12₹194.43₹233.66₹320.40
—−₹36.22−₹4.28₹5.21₹38.08
−₹38.71−₹38.71−₹15.41−₹63.89−₹21.73
—₹0.00₹0.00₹1.50₹1.50
2.22.22.02.02.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASTEC₹581.05

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,295 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS13.04-23.93-68.71-37.79-35.71
Diluted EPS13.04-23.93-68.71-37.79-35.71
Book Value per Share213.90188.32119.70175.30175.30
Revenue per Share320.40233.66194.43201.12196.99
Cash Flow per Share38.085.21-4.28-36.22—
Free Cash Flow per Share-21.73-63.89-15.41-38.71-38.71
Dividends per Share1.501.500.000.00—
Shares Outstanding (cr)2.02.02.02.22.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.